DEF: Perimeter Solutions Reports 2025 Financials, Board Nominees
Proxy Statement
Perimeter Solutions, Inc. announces a 16% increase in net sales to $652.9 million for 2025, alongside a net loss of $206.4 million, and proposes director elections and executive compensation approval at its upcoming May 28, 2026 Annual Meeting.
Summary
- Full year net sales increased 16% to $652.9 million in 2025, up from $561.0 million in the prior year.
- Fire Safety net sales increased 12% to $489.0 million, from $436.3 million in the prior year.
- Specialty Products net sales increased 31% to $163.9 million, from $124.7 million in the prior year.
- Full year net loss was $206.4 million, or $1.37 loss per diluted share, significantly wider than the $5.9 million net loss, or $0.04 loss per diluted share, in the prior year.
- Non-GAAP adjusted earnings per diluted share increased to $1.34, from $1.11 in the prior year.
- Full year Adjusted EBITDA increased 18% to $331.7 million, from $280.3 million in the prior year.
- Fire Safety Segment Adjusted EBITDA increased 21% to $290.5 million, from $240.1 million in the prior year.
- Specialty Products Segment Adjusted EBITDA increased 3% to $41.2 million, from $40.2 million in the prior year.
- The company invested $26.5 million in capital expenditures in 2025.
- The company invested $82.0 million in M&A in 2025, acquiring product lines for its IMS business and select Fire Safety assets from Compass.
- The company repurchased $40.4 million of shares in 2025.
- The 2026 Annual Meeting of Stockholders will be held virtually on May 28, 2026, at 8:00 a.m., Central Time.
- Stockholders will vote on the election of eight director nominees, advisory approval of named executive officer compensation (Say on Pay), and ratification of KPMG LLP as the independent auditor for 2026.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a mixed filing. Strong operational performance indicated by significant growth in net sales and Adjusted EBITDA is offset by a substantial GAAP net loss primarily due to non-operational founder advisory fees, which could concern some investors focusing solely on the bottom line.
Positives
- Strong net sales growth of 16% year-over-year, reaching $652.9 million in 2025.
- Adjusted EBITDA increased by 18% to $331.7 million, indicating improved operational profitability.
- Fire Safety segment net sales grew 12% and its Adjusted EBITDA increased 21%, driven by a cornerstone five-year US Forest Service contract renewal and new business wins.
- Specialty Products segment net sales grew 31%, demonstrating strong expansion in this area.
- Successful M&A activity, investing $82.0 million to acquire product lines for the IMS business and Fire Safety assets, including the announced acquisition of Medical Manufacturing Technologies, LLC (MMT).
- Share repurchases of $40.4 million in 2025, signaling management's confidence in the company's valuation.
- Non-GAAP adjusted earnings per diluted share increased to $1.34 from $1.11.
- Secured a cornerstone five-year US Forest Service contract, culminating a period in which substantially all material retardant contracts were renewed.
- New business wins include rail-applied retardant in Europe and expanded air-based services.
- Productivity gains from a new retardant manufacturing facility outside Sacramento and enhanced multipurpose A/B foam offerings.
Negatives
- Reported a significant net loss of $206.4 million ($1.37 loss per diluted share) in 2025, a substantial increase from the $5.9 million net loss ($0.04 loss per diluted share) in 2024.
- Specialty Products Segment Adjusted EBITDA growth was only 3% ($41.2 million vs. $40.2 million), despite a 31% increase in net sales, suggesting potential margin pressure or higher operating costs in this segment.
- The net loss was heavily influenced by $435.2 million in founder advisory fee expenses in 2025.
Risks
- Subject to extensive federal, state, local, and international laws, regulations, rules, and ordinances relating to safety, pollution, environmental protection, product management, and waste material handling.
- Production facilities require operating permits subject to renewal, modification, and revocation.
- Cybersecurity threats, including data security and privacy incidents, could materially affect the company, its business strategy, results of operations, or financial condition.
- Reliance on third-party vendors for information security introduces risks if those vendors experience cybersecurity threats.
- Fluctuations in the severity of the North American fire season can impact the Fire Safety segment's performance and budget adjustments.
- Litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company.
Future Outlook
The company's equity compensation program is designed to incentivize management to focus on long-term performance and align interests with stockholders by reinforcing the long-term goal of increasing stockholder value and yielding returns comparable to or higher than well-performing private equity funds. The company intends to use actual or estimated Annual Operating Performance (AOP) for a recently completed performance year as the baseline to establish AOP targets for new grants, ensuring growth targets reflect current company goals and serve as a meaningful incentive.
Management Comments
- We emphasize long-term performance and retention of superior executive talent by limiting short-term cash compensation, such as salary and annual incentive payouts, with a focus on long-term equity awards.
- We provide incentives that reward the achievement of performance goals that directly correlate to the enhancement of stockholder value.
- We establish clear financial goals focused on the overall success of the Company.
- We reinforce our mission to recruit and retain a highly motivated workforce to support the overall growth and performance of the Company.
Industry Context
StockSavvy.ai notes that Perimeter Solutions' strong growth in net sales and Adjusted EBITDA, particularly in its Fire Safety segment, suggests resilience and effective strategy execution within its specialized industrial and chemical markets. The significant net loss, primarily driven by founder advisory fees, is a company-specific accounting impact rather than an operational weakness, distinguishing its financial performance from broader industry trends that might focus solely on bottom-line GAAP figures. The M&A activity and focus on productivity initiatives align with a trend of consolidation and efficiency drives seen across mature industrial sectors.
Comparison to Industry Standards
- The company's Adjusted EBITDA growth of 18% to $331.7 million in 2025, compared to its peer group in the industrial and chemical industries (e.g., Arcadium Lithium PLC, Ecovyst, Inc., Ingevity Corporation), indicates strong operational performance.
- The 16% increase in net sales to $652.9 million suggests a robust market position and effective sales strategies relative to competitors.
- The significant net loss of $206.4 million, largely due to founder advisory fees, is an internal financial structure item and not directly comparable to the operational profitability of industry peers without similar founder agreements.
- The company's share repurchase program of $40.4 million in 2025 demonstrates a capital allocation strategy that, when viewed as compelling risk-adjusted return, is consistent with practices of well-managed public companies aiming to enhance shareholder value.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Edward Goldberg | Haitham Khouri | 2023-03-08 | Promotion of Haitham Khouri from Vice Chairman. |
| Vice Chairman | N/A | Edward Goldberg | 2023-03-08 | Transition from CEO role. |
| Chief Financial Officer | N/A (previously VP, Strategy and Corporate Development) | Kyle Sable | 2023-11-16 | Promotion from Vice President, Strategy and Corporate Development. |
| President, Specialty Products | N/A (previously VP of Strategy and Business Development) | Grant Bowman | 2024-10-31 | Promotion from Vice President of Strategy and Business Development. |
| Director | Edward Goldberg | N/A | 2025-05-29 | Not nominated for re-election to the Board at the 2025 Annual Meeting. |
| Vice Chairman | Edward Goldberg | N/A | 2026-03-31 | Departure from Vice Chairman role and transition to consulting. |
| Director | Vivek Raj | N/A | 2026-05-28 | Not nominated for re-election to the Board at the 2026 Annual Meeting. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition | Vivek Raj was not nominated for re-election to the Board and will not continue to serve after the 2026 Annual Meeting, reducing the Board size from nine to eight directors. | 2026-05-28 | Reduces board size, potentially streamlining decision-making, but also reduces overall diversity of thought if not carefully managed. |
| Board Leadership Structure | The Board separates the positions of Chief Executive Officer and Co-Chairmen of the Board to provide strategic guidance and independent oversight. | N/A | Enhances independent oversight of CEO performance and strengthens governance standards. |
| Committee Independence | Audit, Compensation, and Nominating and Corporate Governance Committees are comprised entirely of independent directors, meeting SEC and NYSE requirements. | N/A | Ensures robust independent oversight in critical areas like financial reporting, executive compensation, and director nominations. |
| Risk Oversight | The Board oversees risk management, with the Audit Committee focusing on financial reporting, internal controls, and cybersecurity, and the Executive Committee overseeing enterprise risks and strategy. | N/A | Provides a structured and multi-layered approach to identifying, assessing, and mitigating company risks. |
| Share Retention Guidelines | Executive officers are required to hold a minimum level of personal investment in company shares, with specific thresholds for CEO ($2.2M), CFO ($600K), General Counsel ($450K), President of Fire Safety ($1.2M), and President of Specialty Products ($400K). | N/A | Aligns executive interests with long-term shareholder value creation and promotes accountability. |
| Clawback Policy | Adopted an Executive Officer Clawback Policy in 2023, allowing recovery of incentive-based compensation in the event of an accounting restatement due to material noncompliance with financial reporting requirements. | 2023-XX-XX | Strengthens accountability for financial reporting accuracy and deters misconduct. |
| Insider Trading and Anti-Hedging Policy | Prohibits directors, officers, and employees from engaging in transactions while aware of material non-public information, restricts trading during blackout periods, and prohibits hedging or short sales of company stock. | N/A | Mitigates risks of insider trading and ensures alignment of executive interests with long-term stock performance. |
Legal Proceedings
- Litigation costs of $0.7 million in 2025 arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company.
Related Party Transactions
- The company assumed the Founder Advisory Agreement on November 9, 2021, with the EverArc Founder Entity, owned by William N. Thorndike, Jr., W. Nicholas Howley, Haitham Khouri, Tracy Britt Cool, and Vivek Raj (all current or former directors/executives).
- The EverArc Founder Entity provides strategic and capital allocation advice in exchange for a Variable Annual Advisory Amount and a Fixed Annual Advisory Amount.
- For 2025, both the variable and fixed annual advisory amounts were earned. Approximately 79.6% of the 2025 Advisory Amounts was paid in shares of Common Stock (13,387,003 shares) and approximately 20.4% was paid in cash ($95.7 million).
- The Founder Advisory Agreement can be terminated under specific conditions, triggering a cash payment equal to the fixed and variable annual advisory amounts for the remaining term, with the variable amount increasing by 15% each year.
- The expense related to the fixed and variable founder advisory amounts recognized by the Company was $435.2 million in 2025 and $198.3 million in 2024.
Stakeholder Impact
- Shareholders: Will vote on director elections, executive compensation, and auditor ratification. The significant net loss due to founder advisory fees could impact investor sentiment, despite strong operational metrics. Share repurchases could be positive for shareholder value.
- Employees: Executive compensation program aims to attract, retain, and reward high-performing employees, with long-term equity incentives tied to company performance. Participation in 401(k) and other benefits.
- Customers: Investments in capital expenditures and M&A are focused on supporting customer missions and driving new business. Renewal of key contracts (e.g., US Forest Service) ensures continued service.
- Management: Compensation is heavily tied to company and individual performance, with a focus on long-term equity awards. Share retention guidelines align management interests with shareholders.
- Regulatory Authorities: The company is subject to extensive environmental, health, and safety regulations, and SEC filing requirements, indicating ongoing compliance efforts.
Next Steps
- Hold the 2026 Annual Meeting of Stockholders virtually on May 28, 2026.
- Elect eight director nominees at the Annual Meeting.
- Approve, on an advisory basis, the compensation of named executive officers (Say on Pay).
- Ratify the appointment of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2026.
- Complete the acquisition of Medical Manufacturing Technologies, LLC (MMT) in January 2026.
- Continue to integrate Medical Manufacturing Technologies, LLC (MMT).
- Edward Goldberg will provide advisory and other services to the Company as an independent contractor effective April 1, 2026.
- Stockholder proposals for the 2027 Annual Meeting to be included in proxy materials must be received by December 18, 2026.
- Stockholder proposals and director nominations for the 2027 Annual Meeting not included in proxy materials must be received between January 28, 2027, and February 27, 2027.
Key Dates
| Date | Description |
|---|---|
| 2021-11-08 | Grant date for certain 5-Year Options for Edward Goldberg and Noriko Yokozuka. |
| 2021-11-09 | Consummation of the business combination and effective date of the Founder Advisory Agreement. |
| 2021-12-12 | Date of the original advisory services agreement between EverArc Founder Entity and EverArc. |
| 2022-05-06 | Grant date for certain 5-Year Options for Kyle Sable and Jeffrey Emery. |
| 2023-03-08 | Haitham Khouri named CEO; Edward Goldberg named Vice Chairman; Grant date for certain 5-Year Options for Haitham Khouri. |
| 2023-11-16 | Kyle Sable promoted to CFO; Grant date for certain 5-Year Options for Kyle Sable. |
| 2024-02-14 | Grant date for certain 5-Year Options for Haitham Khouri, Kyle Sable, Noriko Yokozuka, Jeffrey Emery, Grant Bowman, and Edward Goldberg. |
| 2024-05-29 | Edward Goldberg's last day as a director after not being nominated for re-election at the 2025 Annual Meeting. |
| 2024-09-27 | Grant date for certain 5-Year Options for Kyle Sable. |
| 2024-09-30 | Grant Bowman entered into employment agreement as President of Specialty Products. |
| 2024-10-31 | Grant Bowman promoted to President, Specialty Products. |
| 2025-01-01 | Start of fiscal year 2025. |
| 2025-02-12 | Grant date for Annual Extension performance-based nonqualified stock options to NEOs and non-employee independent directors. |
| 2025-02-18 | Date of estimated future payouts under non-equity incentive plan awards for NEOs. |
| 2025-04-21 | Jorge L. Valladares III granted additional performance-based stock options for fiscal 2024 service. |
| 2025-05-28 | 2025 Annual Meeting of Stockholders. |
| 2025-12-23 | Robert S. Henderson and Bernt Iversen II granted additional performance-based stock options for services related to Medical Manufacturing Technologies, LLC integration. |
| 2025-12-31 | End of fiscal year 2025. |
| 2026-01-01 | Acquisition of Medical Manufacturing Technologies, LLC (MMT) completed. |
| 2026-03-31 | Edward Goldberg's effective separation date from Vice Chairman role and transition to consulting role. |
| 2026-04-01 | Edward Goldberg transitioned to an independent contractor role. |
| 2026-04-07 | Record date for the 2026 Annual Meeting of Stockholders. |
| 2026-04-17 | Date of the Notice of 2026 Annual Meeting of Stockholders and Proxy Statement mailing. |
| 2026-05-28 | Date of the 2026 Annual Meeting of Stockholders. |
| 2026-12-18 | Deadline for stockholder proposals for 2027 Annual Meeting to be included in proxy materials. |
| 2026-12-31 | End of fiscal year 2026. |
| 2027-01-28 | Earliest date for stockholder proposals/director nominations for 2027 Annual Meeting not included in proxy materials. |
| 2027-02-27 | Latest date for stockholder proposals/director nominations for 2027 Annual Meeting not included in proxy materials. |
| 2027-12-31 | End of Fixed Annual Advisory Amount term. |
| 2031-12-31 | End of Variable Annual Advisory Amount term. |
Recommendation
holdThe company demonstrates strong operational performance with significant growth in net sales and Adjusted EBITDA, particularly in its Fire Safety segment, and strategic M&A activity. However, the substantial GAAP net loss, primarily driven by founder advisory fees, presents a complex financial picture. While these fees are non-operational, they significantly impact the reported bottom line. Investors should hold to monitor how the market continues to interpret these founder advisory fees and the company's ability to translate operational strength into GAAP profitability over time, especially as the advisory agreement continues until 2031.
Keywords
Perimeter Solutions, SEC Filing, Proxy Statement, DEF 14A, Annual Meeting, Director Election, Executive Compensation, Say on Pay, KPMG LLP, Financial Results, Net Sales, Net Loss, Adjusted EBITDA, Fire Safety, Specialty Products, M&A, Capital Expenditures, Share Repurchase, Corporate Governance, Risk Management, Cybersecurity, Founder Advisory Agreement, Stock Options, Performance-Based Compensation, Shareholder Vote
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.